Definitive Contract HT942626CE004

<p>The Defense Health Agency issued a delivery order to University Of Georgia Research Foundation, Inc. on September 12, 2025, for procurement of Plasmodium berghei-infected Anopheline mosquitoes to support malaria research relevant to warfighter health. The order has a ceiling value of $14,951.70 and an ultimate completion date of January 31, 2026.</p> <p>Place of performance is Silver Spring, MD 20910. The order is firm fixed price with no set-aside designation.</p>

This $3 million firm-fixed-price contract was awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business, under the DHA's Small Business Innovation Research (SBIR) program. The contract supports the development of a &quot;Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics&quot;, aligning with the DHA's mission to provide innovative medical technologies for military healthcare. The contract has an ultimate completion date of...

This is a firm fixed-price definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products and related biological services. The $224,901 contract is for high content screening to identify human primary pancreatic cell type-specific toxicants. This is a small business set-aside contract with a completion date of March 14, 2016. Zenbio has been...

This is a $167,489.14 firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Zymeron Corporation, a minority-owned small business, under the Army's SBIR (Small Business Innovation Research) Phase I program. The contract is for the development of &quot;Rapid Point of Care Diagnostic Tests to Determine Dengue Serostatus&quot;, which aims to create a point-of-care test to assess past exposure to the dengue virus. The contract has a completion date of January 2, 2021....

The Defense Health Agency issued a delivery order to The American National Red Cross on March 23, 2026, for multiple blood products with a ceiling value of $1,499,850.00. The order is issued under a firm fixed-price delivery order structure with no set-aside designation. Place of performance is Falls Church, VA. The ultimate completion date is September 30, 2026. The American National Red Cross operates as the nation's primary supplier of blood and blood products to federal healthcare...

This is a firm fixed price definitive contract awarded by the Defense Health Agency to Biosciences Research Management, Inc., a nonprofit biosciences research organization. The contract, valued at $149,151.24, is for a study related to the Zika virus. The contract does not have a set-aside designation. Biosciences Research Management, Inc. has previously received delivery orders from the Department of the Air Force's Pacific Air Forces to conduct vector-borne disease surveillance and pathogen...

The Defense Health Agency issued a delivery order to The American National Red Cross on December 9, 2025, for multiple blood products with a ceiling value of $250,000. Place of performance is Falls Church, VA. The order is firm fixed price with an ultimate completion date of September 30, 2026. The Red Cross operates as the primary supplier of blood and blood products to federal healthcare agencies, providing whole blood, red blood cells, plasma, platelets, laboratory testing services, and...

The Defense Health Agency issued a delivery order to The American National Red Cross on January 22, 2026, for multiple blood products with a ceiling value of $1,499,900. The order is issued under a parent Blanket Purchase Agreement for blood products and related services. Place of performance is Falls Church, VA. The ultimate completion date is September 30, 2026. The American National Red Cross supplies whole blood, red blood cells, plasma, platelets, and associated laboratory testing...

The Defense Health Agency awarded a $1.61 million firm fixed-price purchase order to Bloodworks (doing business as Puget Sound Blood Center and Program) on February 27, 2024, for blood donor screening tests and supplies. The contract, which has no set-aside designation, supports operations at the U.S. Naval Hospital in Okinawa, Japan, and extends through September 30, 2028. The underlying solicitation, posted on February 20, 2024, sought enzyme immunoassay testing services for blood donor...

The Defense Health Agency (DHA) awarded a $5.42 million firm fixed-price purchase order to Biofire Defense LLC for molecular infectious disease polymerase chain reaction (PCR) testing services, effective October 1, 2025, through September 30, 2026, with an ultimate completion date of September 30, 2030. This non-set-aside contract represents DHA's continued investment in advanced diagnostic capabilities for infectious disease detection and biodefense applications. Biofire Defense, a Salt Lake...